1 – 4 of 4
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
In response to WFH guidelines for the management of haemophilia, 3rd edition : Is there a difference between extended-half-life FVIII products or not?
(
- Contribution to journal › Letter
- 2014
-
Mark
Factor VIII therapy for hemophilia A: current and future issues
(
- Contribution to journal › Scientific review
- 2001
-
Mark
Therapeutic choices for patients with hemophilia and high-titer inhibitors
(
- Contribution to journal › Article
-
Mark
Optimal treatments for patients with bleeding disorders.
(
- Contribution to journal › Letter